COVID-19 Science & Society
How will the world look like in 2022? Is SARS-CoV-2 here to stay with us? While some countries are opening towards normal life, albeit with cautious optimism, others are experiencing the hardest disease burden and public health crisis so far. Will vaccines be effective against new variants and how long the protection will last? What do we know so far about long COVID? Which patient populations could benefit most from emerging therapeutic options? Would there be resistance to new therapies? Subscribe to the COVID-19 Science & Society podcast to find out more on the most relevant and timely topics concerning the COVID pandemic.
Episodes
10 episodes
#10 Ravi Gupta - The Omicron Variant
Ravindra Gupta, MA, MPH, BMBCh, PhD, FRCP, FRCPath, FMedSciUniversity of Cambridge, United Kingdom
•
Season 2
•
Episode 5
•
21:04
#9 Laura Waters - Vaccines and the Immunosuppressed
Laura Waters, MD, FRCPCentral & North West London NHS Foundation Trust, United Kingdom
•
Season 2
•
Episode 4
•
24:47
#8 Monica Gandhi - Vaccine Schedules
Monica Gandhi, MD, MPHUniversity of California San Francisco, United States
•
Season 2
•
Episode 3
•
23:43
#7 Jean Nachega - Scaling up Vaccine Access
Jean Nachega MD, PhD, MPH, FRCP, FAASUniversity of Pittsburgh / Johns Hopkins University, United States Stellenbosch University, South Africa
•
Season 2
•
Episode 2
•
24:22
#6 Karine Lacombe - Vaccine Safety
Karine Lacombe, MD, PhDHôpital Saint Antoine Paris, France
•
Season 2
•
Episode 1
•
23:33
#5 Michel Kazatchkine - Preparedness
Michel Kazatchkine, MDThe Global Health Center, Graduate Institute for International Affairs and DevelopmentReferences:
•
Season 1
•
Episode 5
•
23:28
#4 Kathryn Stephenson - Variants & Vaccines
Kathryn Stephenson, MD, MPHBeth Israel Deaconess Medical Center
•
Season 1
•
Episode 4
•
24:32
#3 Sanjay Bhagani - The Delta Variant
Sanjay Bhagani, BSc, FRCPConsultant Physician in Infectious Diseases/HIV Medicine and General (internal) Medicine, Royal Free Hospital
•
Season 1
•
Episode 3
•
22:56